Condition
Intrapartum Fever
Total Trials
4
Recruiting
1
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
50%
2 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
P 4 (2)
Trial Status
Not Yet Recruiting2
Recruiting1
Withdrawn1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07501221Not ApplicableNot Yet RecruitingPrimary
Intranasal Dexmedetomidine for Prevention of Intrapartum Fever
NCT06682416Not ApplicableRecruiting
The Impact of Local Anesthetic Solution Temperature on Epidural-related Maternal Fever
NCT06950840Phase 4Not Yet RecruitingPrimary
Antipyretic Treatment for Intrapartum Fever: Dipyrone vs Acetaminophen (RCT)
NCT03168178Phase 4Withdrawn
Intrapartum Fever: Antibiotics Versus no Treatment
Showing all 4 trials